Detalles de la búsqueda
1.
Impaired expression of innate immunity-related genes in IgG4-related disease: A possible mechanism in the pathogenesis of IgG4-RD.
Mod Rheumatol
; 30(3): 551-557, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31116057
2.
Isolation of vascular smooth muscle antigen-reactive CD4(+)αßTh1 clones that induce pulmonary vasculitis in MRL/Mp-Fas(+/+) mice.
Cell Immunol
; 303: 50-4, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27019130
3.
Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice.
J Immunol
; 192(3): 979-84, 2014 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24391210
4.
CD4+ T-cell dysfunctions through the impaired lipid rafts ameliorate concanavalin A-induced hepatitis in sphingomyelin synthase 1-knockout mice.
Int Immunol
; 24(5): 327-37, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22345277
5.
[Once-weekly bortezomib plus dexamethasone therapy induced complete response, reducing severe gastrointestinal adverse events for a patient with relapsed multiple myeloma - a case report].
Gan To Kagaku Ryoho
; 39(5): 805-7, 2012 May.
Artículo
en Japonés
| MEDLINE | ID: mdl-22584336
6.
[Primary neurolymphomatosis of the cervical nerve root].
Rinsho Ketsueki
; 51(7): 564-7, 2010 Jul.
Artículo
en Japonés
| MEDLINE | ID: mdl-20693778
7.
[Very good partial response and long time to progression by short-term bortezomib plus dexamethasone therapy for a patient with relapsed and refractory multiple myeloma-a case report].
Gan To Kagaku Ryoho
; 36(8): 1387-9, 2009 Aug.
Artículo
en Japonés
| MEDLINE | ID: mdl-19692786
8.
CD14+ follicular dendritic cells in lymphoid follicles may play a role in the pathogenesis of IgG4-related disease.
Biomed Res
; 36(2): 143-53, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25876665
9.
Prospective clinical study of R-CMD therapy for indolent B cell lymphoma and mantle cell lymphoma from the Hokuriku Hematology Oncology Study Group.
Med Oncol
; 32(9): 232, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26275804
10.
Decreased Expression of Innate Immunity-Related Genes in Peripheral Blood Mononuclear Cells from Patients with IgG4-Related Disease.
PLoS One
; 10(5): e0126582, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25973893
11.
IgG4-related disease: diagnostic methods and therapeutic strategies in Japan.
J Clin Exp Hematop
; 54(2): 95-101, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25318941
12.
Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?
J Clin Exp Hematop
; 53(1): 79-85, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23801138
13.
Daily 500 mg valacyclovir is effective for prevention of Varicella zoster virus reactivation in patients with multiple myeloma treated with bortezomib.
Anticancer Res
; 32(12): 5437-40, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23225448
14.
Skewed production of IL-6 and TGFß by cultured salivary gland epithelial cells from patients with Sjögren's syndrome.
PLoS One
; 7(10): e45689, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23118848
15.
Low-dose cytarabine plus aclarubicin for patients with previously untreated acute myeloid leukemia or high-risk myelodysplastic syndrome ineligible for standard-dose cytarabine plus anthracycline.
Anticancer Res
; 32(4): 1347-53, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22493369
16.
Cutoff Values of Serum IgG4 and Histopathological IgG4+ Plasma Cells for Diagnosis of Patients with IgG4-Related Disease.
Int J Rheumatol
; 2012: 580814, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22654917
17.
[Intravascular large B-cell lymphoma: an important cause of fever of unknown origin].
Brain Nerve
; 63(5): 435-41, 2011 May.
Artículo
en Japonés
| MEDLINE | ID: mdl-21515922
18.
Iron chelation therapy with deferasirox induced complete remission in a patient with chemotherapy-resistant acute monocytic leukemia.
Anticancer Res
; 31(5): 1741-4, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21617233
19.
Efficacy and safety of bortezomib plus dexamethasone therapy for refractory or relapsed multiple myeloma: once-weekly administration of bortezomib may reduce the incidence of gastrointestinal adverse events.
Anticancer Res
; 31(6): 2297-302, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21737655
20.
High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma.
Int J Hematol
; 93(6): 720-726, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21573892